SureTrader Advertisement Advertisement Advertisement
Home > Boards > US Listed > Biotechs >

Novavax (NVAX)

Add NVAX Price Alert      Hide Sticky   Hide Intro
Moderator: No Moderator LongRun8
Search This Board:
Last Post: 9/29/2015 3:40:33 PM - Followers: 129 - Board type: Free - Posts Today: 0


Novavax, Inc. (Nasdaq: NVAX) is a clinical-stage biopharmaceutical company creating recombinant protein nanoparticle vaccines to address a broad range of infectious diseases. The company is developing a portfolio of vaccine candidates targeting seasonal and pandemic influenza (H5N1), a vaccine designed to protect children and the elderly against respiratory syncytial virus (RSV), rabies and other candidates. In addition, the company is developing its vaccine candidates for worldwide commercialization including:

Our world-class scientific team is using VLP technology to tackle influenza viruses – including avian strains that have the potential to cause a pandemic outbreak. Our team has created vaccine candidates that are in various phases of clinical testing designed to protect against various circulating strains of pandemic influenza including H1N1 and H5N1, as well as seasonal influenza. Our recombinant nanoparticle protein micelle technology targeted at RSV has been tested in various preclinical studies and has now advanced into clinical testing.

Our vision is to control the spread of infectious diseases by using a unique single-use manufacturing system that allows for the rapid mass production of recombinant protein nanoparticle vaccines. Our goal is to be able to rapidly deliver a customized vaccine in the midst of a declared pandemic.


President and Chief Executive Officer
Stanley C. Erck

Senior Vice President, Research and Development
Gregory M. Glenn, M.D.

Senior Vice President, Manufacturing and Process Development
Timothy J. Hahn, Ph.D.

Senior Vice President, Chief Financial Officer and Treasurer
Barclay A. "Buck" Phillips

Senior Vice President, Business Development
Russell P. "Rip" Wilson

Vice President, Regulatory Affairs
Amy B. Fix

Vice President, Chief Medical Officer
Louis F. Fries III, M.D.

Vice President, Manufacturing
Mervyn L. Hamer

Vice President, General Counsel and Corporate Secretary
John A. Herrmann III, J.D.

Vice President, Process Development
Erica Shane, Ph.D.

Vice President, Vaccine Development
Gale Smith, Ph.D.

Vice President, Clinical Operations
D. Nigel Thomas, Ph.D.



Novavax’s clinical program includes vaccine candidates designed to address infectious diseases worldwide. Using innovative virus-like particle (VLP) and recombinant nanoparticle technology, as well as new and efficient manufacturing approaches, the company produces vaccine candidates to combat diseases, with the goal of allowing countries to better prepare for and more effectively respond to rapidly spreading infections. Our clinical pipeline is shown below.






  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
Current Price
Bid Ask Day's Range
NVAX News: Novavax Announces Management Promotion 10/01/2015 04:30:00 PM
NVAX News: Current Report Filing (8-k) 09/30/2015 04:17:04 PM
NVAX News: Technical Review on Healthcare and Financial Sectors -- Two Harbors Investments, Hudson City Bancorp, Novavax, Opko Health an... 09/30/2015 10:31:00 AM
NVAX News: Novavax Announces Positive Top-Line Data From RSV F Vaccine Phase 1 Clinical Trial in Pediatrics 09/29/2015 04:02:00 PM
NVAX News: Novavax to Host 3rd Annual Analyst and Investor Meeting 09/29/2015 06:55:00 AM
#2225   Biotech is on a fire sale. nypete 09/29/15 03:40:33 PM
#2224   It wasn't the reason. It was the excuse. Juice Newton 09/29/15 03:12:19 PM
#2223   Another bogus tweet apparently the reason for initial north40000 09/29/15 09:53:37 AM
#2222 Stock price down despite this second PR. north40000 09/29/15 09:37:00 AM
#2221   Novavax Announces Grant of Up to $89 Million LongRun8 09/29/15 09:04:05 AM
#2220   Confidential Treatment Order - CTO sarshee 09/27/15 02:25:09 AM
#2219   What the heck is happening here? Does anyone sarshee 09/27/15 02:18:51 AM
#2218   If there was a secondary coming, Stan would underdog150 09/25/15 04:32:29 PM
#2217   There may be a secondary but I doubt Billcoln 09/23/15 11:41:19 PM
#2216   Has anyone looked at the Jan 2018 options owen3838 09/16/15 10:49:47 PM
#2215   We'll see if there's any info that comes VisionsofSugarPlums 09/08/15 01:25:13 PM
#2214   Hopefully we get positive maternity results for NVAX stockwinner 08/19/15 10:36:36 PM
#2213   Looks like NVAX and all bio techs are sarshee 08/19/15 12:27:41 PM
#2212   NVAX: Good interview of CEO by Cramer on north40000 08/12/15 06:26:32 PM
#2211   Yes, the market for RSV is very significant, LongRun8 08/11/15 02:46:47 PM
#2210   Wow, transcript of CC gives lots of reasons Jon32 08/11/15 07:34:54 AM
#2209   Just bought 1300 in after hour $11.80 devilfromscratch 08/10/15 04:32:27 PM
#2208   Novavax Announces Positive Top-Line Data from Phase 2 LongRun8 08/10/15 04:25:17 PM
#2207   Novavax Announces Positive Data From Phase 2 Trial LongRun8 07/30/15 08:36:59 AM
#2206   Thanks. Please keep your ear to the wall. nypete 07/22/15 03:48:42 PM
#2205   New 52-week intraday high ($13.12) today. EOM. LongRun8 07/21/15 04:32:34 PM
#2204   Ebola trial results out! underdog150 07/21/15 08:49:18 AM
#2203   New 52-week closing high ($12.43) today. EOM. LongRun8 07/20/15 04:10:59 PM
#2202   New 52-week intraday high ($12.76) today. LongRun8 07/15/15 10:33:44 PM
#2201   New 52-week closing high ($12.18) today. LongRun8 07/14/15 04:02:11 PM
#2200   New 52-week intraday high ($12.44) today. LongRun8 07/10/15 05:26:40 PM
#2199   New 52-week intraday high ($12.17) and closing high LongRun8 07/09/15 04:36:51 PM
#2198   Loving the movement. TRUTH 07/09/15 04:21:21 PM
#2197   Hedge fund word is news release mon july volatility magnet 07/09/15 01:04:08 PM
#2196   Glad I added more yesterday stockwinner 07/09/15 09:44:45 AM
#2195   Novavax target raised to $18 ahead of vaccine underdog150 07/09/15 08:45:25 AM
#2194   It'll break through it tomorrow TOM611 07/07/15 04:49:33 PM
#2193   New 52-week closing high ($11.355) today. LongRun8 07/07/15 04:02:54 PM
#2192   It will this. Yearrt TOM611 07/05/15 08:36:43 PM
#2191   Didn't* stockwinner 07/02/15 04:56:16 PM
#2190   Did hit 15 :) as u predicted stockwinner 07/02/15 04:05:17 PM
#2189   Haha it was thanks stockwinner 06/30/15 06:12:18 PM
#2188   Apparently a good move. ;-) TRUTH 06/30/15 06:00:55 PM
#2187   The market tanked big time wow stockwinner 06/29/15 04:22:35 PM
#2186   I grabbed more at 10.50 :) stockwinner 06/29/15 09:45:50 AM
#2185   Nvax hits 15. This week. TOM611 06/29/15 08:24:54 AM
#2184   Haha am not short at all I am a stockwinner 06/28/15 07:31:58 PM
#2183   You either have this heavily shorted or you ThatBobGuy 06/28/15 07:07:49 PM
#2182   Bloodbath in market tomorrow NVAX to 10$ stockwinner 06/28/15 06:16:33 PM
#2181   40 millys worth bought after hours. Go. Nvax TOM611 06/28/15 05:55:23 PM
#2180   Four trial results projected to be released third LongRun8 06/25/15 09:02:33 AM
#2179   Very interesting indeed. TRUTH 06/24/15 08:47:13 PM
#2178   New 52-week intraday high ($11.45) and closing high LongRun8 06/24/15 04:12:05 PM
#2177   It lost the steam and will retrace a stockwinner 06/24/15 01:19:40 PM
#2176   $30 stockwinner 06/24/15 11:39:57 AM